Publications by authors named "N Tachikawa"
Article Synopsis
- Persistent inflammation in people living with HIV (PWH) may influence their immune response to SARS-CoV-2 infection differently than in HIV-uninfected individuals.
- During a study, proinflammatory cytokine levels were measured in PWH, revealing no significant differences in cytokine levels across various COVID-19 severity levels, unlike in HIV-uninfected individuals where higher levels correlated with severe cases.
- The findings indicate that PWH are in a heightened inflammatory state but exhibit distinct inflammatory responses to SARS-CoV-2 compared to the general population, possibly due to impairments in their immune cells and existing inflammation.
Introduction: Guidelines recommend that patients with acute venous thromboembolism (VTE) represented by low-risk deep vein thrombosis (DVT) and pulmonary embolism (PE) receive initial treatment at home versus at the hospital, but a large percentage of these patients are not managed at home. This study assessed the effectiveness of a quality intervention on provider knowledge and confidence in evaluating outpatient treatment for patients with VTE in the emergency department (ED).
Methods: A pilot program to overcome obstacles to outpatient VTE treatment in appropriate patients was initiated at Baylor Scott & White Health Temple ED.
Background: 5-aminolevulinic acid (5-ALA), a natural amino acid that is marketed alongside sodium ferrous citrate (SFC) as a functional food, blocks severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proliferation in vitro and exerts anti-inflammatory effects. In this phase II open-label, prospective, parallel-group, randomized trial, we aimed to evaluate the safety and efficacy of 5-ALA in patients with mild-to-moderate coronavirus disease 2019.
Methods: This trial was conducted in patients receiving 5-ALA/SFC (250/145 mg) orally thrice daily for 7 days, followed by 5-ALA/SFC (150/87 mg) orally thrice daily for 7 days.
Background: Short implants have been proposed as an alternative solution for the rehabilitation of atrophic posterior region.
Purpose: To compare the clinical outcomes between 6 mm short implants and conventional implants placed under similar conditions of bone quality and occlusal loading.
Materials And Methods: Nine patients received atone 6 mm implant and one standard-length (8 mm length or longer) implants in a total of 10 partially edentulous areas.
SARS-CoV-2 continues to spread worldwide. Patients with COVID-19 show distinct clinical symptoms. Although many studies have reported various causes for the diversity of symptoms, the underlying mechanisms are not fully understood.
View Article and Find Full Text PDF